NEW YORK (TheStreet) -- CHANGE IN RATINGS
rated new Buy at Citigroup. $67 price target. Company is positioned to see accelerating sales growth.
rated new Equal-weight at Morgan Stanley. Market share losses could offset growth from new ventures.
downgraded at Barclays to Equal Weight from Overweight and price target cut to $52 from $63. Persistent Overhang on consent Decree, Barclays said. 2010 and 2011 EPS estimates lowered to $2.31 and $3.68, respectively.
rated new Neutral at Goldman. $17 price target. Company has dominant market share in the residential market and generates significant free cash flow.
rated new Overweight at Morgan Stanley. JNPR was initiated with an Overweight rating. $37 price target. Ethernet switching market should drive sales and earnings growth.
RTI International Metals
downgraded at BofA/Merrill to Underperform from Neutral. Valuation call, Bank of America/Merrill Lynch said. Price target raised to $32 from $24. Maintain 2010 and 2011 EPS estimates at -$0.60 and $0.30, respectively.
upgraded at JP Morgan. Rating raised to Overweight from Neutral. Price target raised to $28 from $21. Maintains 2010 EPS estimates of $1.50.
STOCK COMMENTS / EPS CHANGES
Archer Daniels Midland
target, estimates cut at BofA/Merrill. ADM price target lowered to $34 from $37 as ethanol sentiment is driving stock weakness. 2010 and 2011 EPS estimates both lowered to $2.90. Maintain Buy rating.
target, estimates higher at BofA/Merrill. APOL 2010 and 2011 EPS estimates increased to $5.10 and $5.93, respectively. Strategic shift continues. Price target raised by a dollar to $69. Maintain Neutral rating.
estimates lowered at UBS through 2011. Company lowered guidance. Buy rating and $120 price target.
estimates, target raised at UBS. AVT estimates were increased through 2011. Company pre-announced earnings and should also benefit from the BELM acquisition. Buy rating and new $35 price target.
estimates lowered at UBS through 2011. Company is seeing higher catastrophe losses. Buy rating and $56 price target.
target boosted at Citigroup. Shares of CELG now seen reaching $72. Company could deliver higher Revlimid growth in Europe. Buy rating.
target raised at UBS to $70. Higher spot commodity prices are helping contract pricing. Buy rating.
estimates boosted at UBS through 2011. Channel checks are showing positive keyword pricing. Buy rating and $700 price target.
2010 and 2011 estimates boosted at Barclays to $18.28 and $20.23, respectively. Raising out FICC and principal investment gains estimates. Maintain Equal weight rating and $95 price target.
numbers increased at Citigroup through 2012. Company is growing market share and the developing markets outlook is robust. Buy rating and new $60 price target.
estimates cut at Barclays MS 2010 and 2011 EPS estimates trimmed to $2.43 and $3.33, respectively. Barclays noted weaker trading revenues. Reiterate Equal Weight rating and $34 target.
estimates upped at UBS. MU estimates were increased through 2011. Strong demand should drive higher near-term results. Neutral rating and $10.50 price target.
estimates, target boosted at FBR. Shares of NFLX now seen reaching $85. Estimates also raised, as the company should continue to deliver subscriber and margin growth. Outperform rating.
estimates, target raised at Citigroup. Shares of NVDA now seen reaching $24. Estimates were also boosted, following positive channel checks. Buy rating.
Research in Motion
estimates increased at Kaufman through 2011. Company will likely post strong earnings, driven by sales of the Curve and Bold devices. Buy rating.
This article was written by a staff member of TheStreet.com.